組換えタンパク質の世界市場規模、シェア、産業動向分析レポート：製品別、エンドユーザー別、用途別、地域別展望および予測、2022年～2028年

組換えタンパク質の世界市場規模は、予測期間中にCAGR10.8％で成長し、2028年には26億米ドルに達すると予測されます。

この事業の成長は、肉芽腫性疾患、血友病、硬化症などの慢性疾患の発生率の増加によって促進されると予測されます。さらに、組換えタンパク質製品の改良、生物製剤やバイオシミラーへの嗜好の高まり、その他の理由もすべて、業界の拡大に寄与しています。SARS-CoV2ウイルスの治療薬や診断ツールの発見競争は、COVID-19の流行で盛り上がりました。

Global Genesによると、世界には4億人以上の人々がまれな遺伝性疾患に苦しんでいます。この数字は、治療法、ヘルスケア環境の改善、健康問題に対する一般の人々の知識の向上が急務であることを示しています。医薬品を生み出すためには、最先端の研究と薬物標的メカニズムに関する知識が不可欠です。

コホートプログラムにより、いくつかの地域ではバイオバンクが構築され、研究者は治療努力に革命をもたらす高品質のサンプルにアクセスできるようになりました。これにより、様々な病気のバイオマーカーの特定がより重視されるようになるかもしれません。例として、FDAは2022年8月、希少な血液疾患である進行性全身性肥満細胞症に対処するため、Ayvakitを承認しました。

COVID-19影響度分析

COVID-19ワクチンは、迅速かつ大規模な開発が要求され、商業的な製造活動も継続していることから、生物製剤を用いた研究の取り組みに好ましい影響を与え、結果的に業界の拡大に寄与しました。COVID-19のパンデミックは、タンパク質市場の拡大に好ましい影響を与えました。SARS-CoV-2感染に対してより効果的で、センターで容易に入手できる、異なるアジュバントと抗原のサブユニットを組み合わせた組換えタンパク質ワクチンが開発されるかもしれない、とCOVID感染の拡大に照らして提案されました。

市場の成長要因

慢性疾患の増加によるオーダーメイド医療への注目の高まり

組換えタンパク質は、慢性疾患に対する数少ない治療法として認知されており、慢性疾患が増加傾向にあることから、組換えタンパク質治療に対する需要は大きいです。GLOBOCANによると、2020年にメキシコで新たに発生するがん患者は195,499人、がん関連死は90,222人と推定されています。ワクチン、組換えタンパク質、細胞・遺伝子治療など、いくつかのバイオテクノロジーは、治療の個別化に不可欠であるため、個別化医療の開発に組み込まれる必要があります。

生物製剤の研究開発の増加

組換えタンパク質の市場は、生物製剤の研究開発の増加により、需要が拡大すると予想されます。研究開発産業は、長い研究期間と規制の遅れにより、従来から多くの資金を必要としてきました。研究開発に対する消費は、世界の支出の中でかなりの割合を占めています。各国政府は、研究開発を国家の発展、国際競争力、公益のための重要な要因として認識しています。その結果、研究開発の資金と支出は着実に増加しています。

市場の抑制要因

遺伝子組換えタンパク質が安価になってきています。

リコンビナント・タンパク質は、研究室で培養された細胞を使って作られるため、高価格の一因となっています。また、製造コストの8割を占めるといわれる精製も大きな経費の一つです。価格侵食とは、特定の市場に多くのプレーヤーが参入し、独自性のない同一商品を販売し、創造性のないリーズナブルな価格の商品で市場を飽和させることであると定義されています。価格侵食とは、ある市場においてこれらの製品の価格が常に低下し、市場の拡大が鈍化することです。

製品の展望

製品別では、成長因子およびケモカイン、免疫反応タンパク質、構造タンパク質、膜タンパク質、キナーゼタンパク質、制御タンパク質、組み換え代謝酵素、接着分子および受容体、その他の組換えタンパク質に分類されます。2021年には、免疫反応タンパク質がかなりの売上シェアを占めると予想されます。体内の重要なタンパク質群にサイトカインがあります。これらの小さなタンパク質は、免疫システムのメッセンジャーとして機能します。免疫系の連絡網として機能し、脅威に対する反応として生み出されます。免疫系細胞は、互いに直接触れることで相互作用することもあるが、より頻繁にはサイトカインを分泌することで近くの細胞や遠くの細胞に作用することができます。

アプリケーションの展望

アプリケーション別に見ると、創薬・市場開拓、バイオ医薬品生産、バイオテクノロジー研究、学術研究、診断、その他のアプリケーションに分類されます。バイオテクノロジー研究は、2021年に大きな収益シェアを占めています。組換えタンパク質は、生物の基本的かつ根本的な原理を照らし出すのに役立ちます。これらの分子は、特定の遺伝子がコードするタンパク質の位置を特定し、ピンポイントで特定するために使用することができ、また、他の遺伝子が細胞シグナル伝達、代謝、成長、複製、死、翻訳、転写、タンパク質修飾などのプロセスにどのように関与しているかについてより詳しく知ることができます。

エンドユーザーの展望

組換えタンパク質市場は、エンドユーザーに基づき、製薬・バイオ医薬品業界、バイオテクノロジー業界、学術研究機関、受託研究機関、その他のエンドユーザーに分類されます。受託研究機関は、2021年の市場収益のかなりの部分を占めると予想されます。研究開発業界では、学術機関と企業間のパートナーシップやコラボレーションに関する投資が増加しました。例えば、ファイザーの治療イノベーションセンター（CTI）は、ヘルスケアシステムにおける利害関係者間の交流の場として機能しています。

地域別の展望

地域別に見ると、遺伝子組換えタンパク質市場は北米、欧州、アジア太平洋、LAMEAに分類されます。2021年の組換えタンパク質の主要地域市場は、北米でした。慢性疾患や遺伝性疾患の高い有病率、研究開発のための資金の確保、製薬業界の研究開発に対する政府の取り組み、研究・学術分野におけるライフサイエンス技術の利用の拡大、大手製薬・バイオテクノロジー企業の大きな存在、創薬・研究開発における分析機器の応用などが、北米が世界市場で大きなシェアを占めている要因となっているようです。

目次

第1章 市場の範囲と調査手法

• 市場の定義
• 目的
• 市場規模
• セグメンテーション
  • 組換えタンパク質の世界市場、製品別
  • 組換えタンパク質の世界市場、エンドユーザー別
  • 組換えタンパク質の世界市場、用途別
  • 組換えタンパク質の世界市場、地域別
• 調査手法

第2章 市場概要

• イントロダクション
  • 概要説明
    • 市場の構成とシナリオ
• 市場に影響を与える主な要因
  • 市場促進要因
  • 市場の抑制要因

第3章 組換えタンパク質市場で展開されている戦略

第4章 組換えタンパク質の世界市場：製品別

• 成長因子とケモカインの世界市場：地域別
• 組換え代謝酵素、接着分子、受容体の世界市場：地域別
• 構造タンパク質の世界市場：地域別
• 膜タンパク質の世界市場：地域別
• キナーゼ蛋白質・制御蛋白質の世界市場：地域別
• 免疫応答タンパク質の世界市場：地域別
• その他の地域別世界市場

第5章 組換えタンパク質の世界市場：エンドユーザー別

• 製薬会社・バイオ製薬会社の世界市場：地域別
• バイオテクノロジー企業の世界市場：地域別
• 学術研究機関の世界市場：地域別
• 受託研究機関の世界市場：地域別
• その他の地域別世界市場

第6章 組換えタンパク質の世界市場：アプリケーション別

• 創薬・市場開拓の世界市場：地域別
• 学術調査研究の世界市場：地域別
• バイオ医薬品の世界生産市場：地域別
• 診断の世界市場：地域別
• バイオテクノロジー研究の世界市場：地域別
• 世界の地域別その他市場

第7章：組換えタンパク質の世界市場：地域別

• 北米
  • 北米の組換えタンパク質国別市場
    • 米国
    • カナダ
    • メキシコ
    • その他北米地域
• 欧州
  • 欧州の組換えタンパク質市場：国別
    • ドイツ
    • 英国
    • フランス
    • ロシア
    • スペイン
    • イタリア
    • その他欧州
• アジア太平洋地域
  • アジア太平洋地域の組換えタンパク質市場：国別
    • 中国
    • 日本
    • インド
    • 韓国
    • シンガポール
    • マレーシア
    • その他アジア太平洋地域
• LAMEA
  • LAMEAの組換えタンパク質市場：国別
    • ブラジル
    • アルゼンチン
    • UAE
    • サウジアラビア
    • 南アフリカ共和国
    • ナイジェリア
    • LAMEAの他の地域

第8章 企業プロファイル

• Bio-Techne Corporation
• Thermo Fisher Scientific, Inc.
• Merck Group
• Bio-Rad laboratories, Inc.
• Abcam plc
• Genscript Biotech Corporation
• Miltenyi Biotech B.V. & Co. KG
• Proteintech Group, Inc.
• BPS Bioscience, Inc.
• RayBiotech Life, Inc.

LIST OF TABLES

• TABLE 1 Global Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 2 Global Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 3 Global Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 4 Global Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 5 Global Growth Factors & Chemokines Market by Region, 2018 - 2021, USD Million
• TABLE 6 Global Growth Factors & Chemokines Market by Region, 2022 - 2028, USD Million
• TABLE 7 Global Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Region, 2018 - 2021, USD Million
• TABLE 8 Global Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Region, 2022 - 2028, USD Million
• TABLE 9 Global Structural Proteins Market by Region, 2018 - 2021, USD Million
• TABLE 10 Global Structural Proteins Market by Region, 2022 - 2028, USD Million
• TABLE 11 Global Membrane Proteins Market by Region, 2018 - 2021, USD Million
• TABLE 12 Global Membrane Proteins Market by Region, 2022 - 2028, USD Million
• TABLE 13 Global Kinase Proteins & Regulatory Proteins Market by Region, 2018 - 2021, USD Million
• TABLE 14 Global Kinase Proteins & Regulatory Proteins Market by Region, 2022 - 2028, USD Million
• TABLE 15 Global Immune Response Proteins Market by Region, 2018 - 2021, USD Million
• TABLE 16 Global Immune Response Proteins Market by Region, 2022 - 2028, USD Million
• TABLE 17 Global Others Market by Region, 2018 - 2021, USD Million
• TABLE 18 Global Others Market by Region, 2022 - 2028, USD Million
• TABLE 19 Global Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 20 Global Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 21 Global Pharmaceutical & Biopharmaceutical Companies Market by Region, 2018 - 2021, USD Million
• TABLE 22 Global Pharmaceutical & Biopharmaceutical Companies Market by Region, 2022 - 2028, USD Million
• TABLE 23 Global Biotechnology Companies Market by Region, 2018 - 2021, USD Million
• TABLE 24 Global Biotechnology Companies Market by Region, 2022 - 2028, USD Million
• TABLE 25 Global Academic Research Institutes Market by Region, 2018 - 2021, USD Million
• TABLE 26 Global Academic Research Institutes Market by Region, 2022 - 2028, USD Million
• TABLE 27 Global Contract Research Organizations Market by Region, 2018 - 2021, USD Million
• TABLE 28 Global Contract Research Organizations Market by Region, 2022 - 2028, USD Million
• TABLE 29 Global Others Market by Region, 2018 - 2021, USD Million
• TABLE 30 Global Others Market by Region, 2022 - 2028, USD Million
• TABLE 31 Global Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 32 Global Recombinant Proteins Market by Application, 2022 - 2028, USD Million
• TABLE 33 Global Drug Discovery & Development Market by Region, 2018 - 2021, USD Million
• TABLE 34 Global Drug Discovery & Development Market by Region, 2022 - 2028, USD Million
• TABLE 35 Global Academic Research Studies Market by Region, 2018 - 2021, USD Million
• TABLE 36 Global Academic Research Studies Market by Region, 2022 - 2028, USD Million
• TABLE 37 Global Biopharmaceutical Production Market by Region, 2018 - 2021, USD Million
• TABLE 38 Global Biopharmaceutical Production Market by Region, 2022 - 2028, USD Million
• TABLE 39 Global Diagnostics Market by Region, 2018 - 2021, USD Million
• TABLE 40 Global Diagnostics Market by Region, 2022 - 2028, USD Million
• TABLE 41 Global Biotechnology Research Market by Region, 2018 - 2021, USD Million
• TABLE 42 Global Biotechnology Research Market by Region, 2022 - 2028, USD Million
• TABLE 43 Global Others Market by Region, 2018 - 2021, USD Million
• TABLE 44 Global Others Market by Region, 2022 - 2028, USD Million
• TABLE 45 Global Recombinant Proteins Market by Region, 2018 - 2021, USD Million
• TABLE 46 Global Recombinant Proteins Market by Region, 2022 - 2028, USD Million
• TABLE 47 North America Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 48 North America Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 49 North America Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 50 North America Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 51 North America Growth Factors & Chemokines Market by Country, 2018 - 2021, USD Million
• TABLE 52 North America Growth Factors & Chemokines Market by Country, 2022 - 2028, USD Million
• TABLE 53 North America Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2018 - 2021, USD Million
• TABLE 54 North America Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2022 - 2028, USD Million
• TABLE 55 North America Structural Proteins Market by Country, 2018 - 2021, USD Million
• TABLE 56 North America Structural Proteins Market by Country, 2022 - 2028, USD Million
• TABLE 57 North America Membrane Proteins Market by Country, 2018 - 2021, USD Million
• TABLE 58 North America Membrane Proteins Market by Country, 2022 - 2028, USD Million
• TABLE 59 North America Kinase Proteins & Regulatory Proteins Market by Country, 2018 - 2021, USD Million
• TABLE 60 North America Kinase Proteins & Regulatory Proteins Market by Country, 2022 - 2028, USD Million
• TABLE 61 North America Immune Response Proteins Market by Country, 2018 - 2021, USD Million
• TABLE 62 North America Immune Response Proteins Market by Country, 2022 - 2028, USD Million
• TABLE 63 North America Others Market by Country, 2018 - 2021, USD Million
• TABLE 64 North America Others Market by Country, 2022 - 2028, USD Million
• TABLE 65 North America Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 66 North America Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 67 North America Pharmaceutical & Biopharmaceutical Companies Market by Country, 2018 - 2021, USD Million
• TABLE 68 North America Pharmaceutical & Biopharmaceutical Companies Market by Country, 2022 - 2028, USD Million
• TABLE 69 North America Biotechnology Companies Market by Country, 2018 - 2021, USD Million
• TABLE 70 North America Biotechnology Companies Market by Country, 2022 - 2028, USD Million
• TABLE 71 North America Academic Research Institutes Market by Country, 2018 - 2021, USD Million
• TABLE 72 North America Academic Research Institutes Market by Country, 2022 - 2028, USD Million
• TABLE 73 North America Contract Research Organizations Market by Country, 2018 - 2021, USD Million
• TABLE 74 North America Contract Research Organizations Market by Country, 2022 - 2028, USD Million
• TABLE 75 North America Others Market by Country, 2018 - 2021, USD Million
• TABLE 76 North America Others Market by Country, 2022 - 2028, USD Million
• TABLE 77 North America Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 78 North America Recombinant Proteins Market by Application, 2022 - 2028, USD Million
• TABLE 79 North America Drug Discovery & Development Market by Country, 2018 - 2021, USD Million
• TABLE 80 North America Drug Discovery & Development Market by Country, 2022 - 2028, USD Million
• TABLE 81 North America Academic Research Studies Market by Country, 2018 - 2021, USD Million
• TABLE 82 North America Academic Research Studies Market by Country, 2022 - 2028, USD Million
• TABLE 83 North America Biopharmaceutical Production Market by Country, 2018 - 2021, USD Million
• TABLE 84 North America Biopharmaceutical Production Market by Country, 2022 - 2028, USD Million
• TABLE 85 North America Diagnostics Market by Country, 2018 - 2021, USD Million
• TABLE 86 North America Diagnostics Market by Country, 2022 - 2028, USD Million
• TABLE 87 North America Biotechnology Research Market by Country, 2018 - 2021, USD Million
• TABLE 88 North America Biotechnology Research Market by Country, 2022 - 2028, USD Million
• TABLE 89 North America Others Market by Country, 2018 - 2021, USD Million
• TABLE 90 North America Others Market by Country, 2022 - 2028, USD Million
• TABLE 91 North America Recombinant Proteins Market by Country, 2018 - 2021, USD Million
• TABLE 92 North America Recombinant Proteins Market by Country, 2022 - 2028, USD Million
• TABLE 93 US Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 94 US Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 95 US Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 96 US Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 97 US Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 98 US Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 99 US Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 100 US Recombinant Proteins Market by Application, 2022 - 2028, USD Million
• TABLE 101 Canada Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 102 Canada Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 103 Canada Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 104 Canada Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 105 Canada Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 106 Canada Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 107 Canada Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 108 Canada Recombinant Proteins Market by Application, 2022 - 2028, USD Million
• TABLE 109 Mexico Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 110 Mexico Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 111 Mexico Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 112 Mexico Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 113 Mexico Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 114 Mexico Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 115 Mexico Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 116 Mexico Recombinant Proteins Market by Application, 2022 - 2028, USD Million
• TABLE 117 Rest of North America Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 118 Rest of North America Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 119 Rest of North America Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 120 Rest of North America Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 121 Rest of North America Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 122 Rest of North America Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 123 Rest of North America Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 124 Rest of North America Recombinant Proteins Market by Application, 2022 - 2028, USD Million
• TABLE 125 Europe Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 126 Europe Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 127 Europe Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 128 Europe Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 129 Europe Growth Factors & Chemokines Market by Country, 2018 - 2021, USD Million
• TABLE 130 Europe Growth Factors & Chemokines Market by Country, 2022 - 2028, USD Million
• TABLE 131 Europe Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2018 - 2021, USD Million
• TABLE 132 Europe Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2022 - 2028, USD Million
• TABLE 133 Europe Structural Proteins Market by Country, 2018 - 2021, USD Million
• TABLE 134 Europe Structural Proteins Market by Country, 2022 - 2028, USD Million
• TABLE 135 Europe Membrane Proteins Market by Country, 2018 - 2021, USD Million
• TABLE 136 Europe Membrane Proteins Market by Country, 2022 - 2028, USD Million
• TABLE 137 Europe Kinase Proteins & Regulatory Proteins Market by Country, 2018 - 2021, USD Million
• TABLE 138 Europe Kinase Proteins & Regulatory Proteins Market by Country, 2022 - 2028, USD Million
• TABLE 139 Europe Immune Response Proteins Market by Country, 2018 - 2021, USD Million
• TABLE 140 Europe Immune Response Proteins Market by Country, 2022 - 2028, USD Million
• TABLE 141 Europe Others Market by Country, 2018 - 2021, USD Million
• TABLE 142 Europe Others Market by Country, 2022 - 2028, USD Million
• TABLE 143 Europe Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 144 Europe Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 145 Europe Pharmaceutical & Biopharmaceutical Companies Market by Country, 2018 - 2021, USD Million
• TABLE 146 Europe Pharmaceutical & Biopharmaceutical Companies Market by Country, 2022 - 2028, USD Million
• TABLE 147 Europe Biotechnology Companies Market by Country, 2018 - 2021, USD Million
• TABLE 148 Europe Biotechnology Companies Market by Country, 2022 - 2028, USD Million
• TABLE 149 Europe Academic Research Institutes Market by Country, 2018 - 2021, USD Million
• TABLE 150 Europe Academic Research Institutes Market by Country, 2022 - 2028, USD Million
• TABLE 151 Europe Contract Research Organizations Market by Country, 2018 - 2021, USD Million
• TABLE 152 Europe Contract Research Organizations Market by Country, 2022 - 2028, USD Million
• TABLE 153 Europe Others Market by Country, 2018 - 2021, USD Million
• TABLE 154 Europe Others Market by Country, 2022 - 2028, USD Million
• TABLE 155 Europe Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 156 Europe Recombinant Proteins Market by Application, 2022 - 2028, USD Million
• TABLE 157 Europe Drug Discovery & Development Market by Country, 2018 - 2021, USD Million
• TABLE 158 Europe Drug Discovery & Development Market by Country, 2022 - 2028, USD Million
• TABLE 159 Europe Academic Research Studies Market by Country, 2018 - 2021, USD Million
• TABLE 160 Europe Academic Research Studies Market by Country, 2022 - 2028, USD Million
• TABLE 161 Europe Biopharmaceutical Production Market by Country, 2018 - 2021, USD Million
• TABLE 162 Europe Biopharmaceutical Production Market by Country, 2022 - 2028, USD Million
• TABLE 163 Europe Diagnostics Market by Country, 2018 - 2021, USD Million
• TABLE 164 Europe Diagnostics Market by Country, 2022 - 2028, USD Million
• TABLE 165 Europe Biotechnology Research Market by Country, 2018 - 2021, USD Million
• TABLE 166 Europe Biotechnology Research Market by Country, 2022 - 2028, USD Million
• TABLE 167 Europe Others Market by Country, 2018 - 2021, USD Million
• TABLE 168 Europe Others Market by Country, 2022 - 2028, USD Million
• TABLE 169 Europe Recombinant Proteins Market by Country, 2018 - 2021, USD Million
• TABLE 170 Europe Recombinant Proteins Market by Country, 2022 - 2028, USD Million
• TABLE 171 Germany Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 172 Germany Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 173 Germany Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 174 Germany Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 175 Germany Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 176 Germany Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 177 Germany Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 178 Germany Recombinant Proteins Market by Application, 2022 - 2028, USD Million
• TABLE 179 UK Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 180 UK Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 181 UK Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 182 UK Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 183 UK Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 184 UK Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 185 UK Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 186 UK Recombinant Proteins Market by Application, 2022 - 2028, USD Million
• TABLE 187 France Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 188 France Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 189 France Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 190 France Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 191 France Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 192 France Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 193 France Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 194 France Recombinant Proteins Market by Application, 2022 - 2028, USD Million
• TABLE 195 Russia Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 196 Russia Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 197 Russia Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 198 Russia Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 199 Russia Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 200 Russia Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 201 Russia Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 202 Russia Recombinant Proteins Market by Application, 2022 - 2028, USD Million
• TABLE 203 Spain Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 204 Spain Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 205 Spain Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 206 Spain Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 207 Spain Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 208 Spain Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 209 Spain Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 210 Spain Recombinant Proteins Market by Application, 2022 - 2028, USD Million
• TABLE 211 Italy Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 212 Italy Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 213 Italy Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 214 Italy Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 215 Italy Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 216 Italy Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 217 Italy Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 218 Italy Recombinant Proteins Market by Application, 2022 - 2028, USD Million
• TABLE 219 Rest of Europe Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 220 Rest of Europe Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 221 Rest of Europe Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 222 Rest of Europe Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 223 Rest of Europe Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 224 Rest of Europe Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 225 Rest of Europe Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 226 Rest of Europe Recombinant Proteins Market by Application, 2022 - 2028, USD Million
• TABLE 227 Asia Pacific Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 228 Asia Pacific Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 229 Asia Pacific Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 230 Asia Pacific Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 231 Asia Pacific Growth Factors & Chemokines Market by Country, 2018 - 2021, USD Million
• TABLE 232 Asia Pacific Growth Factors & Chemokines Market by Country, 2022 - 2028, USD Million
• TABLE 233 Asia Pacific Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2018 - 2021, USD Million
• TABLE 234 Asia Pacific Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2022 - 2028, USD Million
• TABLE 235 Asia Pacific Structural Proteins Market by Country, 2018 - 2021, USD Million
• TABLE 236 Asia Pacific Structural Proteins Market by Country, 2022 - 2028, USD Million
• TABLE 237 Asia Pacific Membrane Proteins Market by Country, 2018 - 2021, USD Million
• TABLE 238 Asia Pacific Membrane Proteins Market by Country, 2022 - 2028, USD Million
• TABLE 239 Asia Pacific Kinase Proteins & Regulatory Proteins Market by Country, 2018 - 2021, USD Million
• TABLE 240 Asia Pacific Kinase Proteins & Regulatory Proteins Market by Country, 2022 - 2028, USD Million
• TABLE 241 Asia Pacific Immune Response Proteins Market by Country, 2018 - 2021, USD Million
• TABLE 242 Asia Pacific Immune Response Proteins Market by Country, 2022 - 2028, USD Million
• TABLE 243 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
• TABLE 244 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
• TABLE 245 Asia Pacific Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 246 Asia Pacific Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 247 Asia Pacific Pharmaceutical & Biopharmaceutical Companies Market by Country, 2018 - 2021, USD Million
• TABLE 248 Asia Pacific Pharmaceutical & Biopharmaceutical Companies Market by Country, 2022 - 2028, USD Million
• TABLE 249 Asia Pacific Biotechnology Companies Market by Country, 2018 - 2021, USD Million
• TABLE 250 Asia Pacific Biotechnology Companies Market by Country, 2022 - 2028, USD Million
• TABLE 251 Asia Pacific Academic Research Institutes Market by Country, 2018 - 2021, USD Million
• TABLE 252 Asia Pacific Academic Research Institutes Market by Country, 2022 - 2028, USD Million
• TABLE 253 Asia Pacific Contract Research Organizations Market by Country, 2018 - 2021, USD Million
• TABLE 254 Asia Pacific Contract Research Organizations Market by Country, 2022 - 2028, USD Million
• TABLE 255 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
• TABLE 256 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
• TABLE 257 Asia Pacific Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 258 Asia Pacific Recombinant Proteins Market by Application, 2022 - 2028, USD Million
• TABLE 259 Asia Pacific Drug Discovery & Development Market by Country, 2018 - 2021, USD Million
• TABLE 260 Asia Pacific Drug Discovery & Development Market by Country, 2022 - 2028, USD Million
• TABLE 261 Asia Pacific Academic Research Studies Market by Country, 2018 - 2021, USD Million
• TABLE 262 Asia Pacific Academic Research Studies Market by Country, 2022 - 2028, USD Million
• TABLE 263 Asia Pacific Biopharmaceutical Production Market by Country, 2018 - 2021, USD Million
• TABLE 264 Asia Pacific Biopharmaceutical Production Market by Country, 2022 - 2028, USD Million
• TABLE 265 Asia Pacific Diagnostics Market by Country, 2018 - 2021, USD Million
• TABLE 266 Asia Pacific Diagnostics Market by Country, 2022 - 2028, USD Million
• TABLE 267 Asia Pacific Biotechnology Research Market by Country, 2018 - 2021, USD Million
• TABLE 268 Asia Pacific Biotechnology Research Market by Country, 2022 - 2028, USD Million
• TABLE 269 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
• TABLE 270 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
• TABLE 271 Asia Pacific Recombinant Proteins Market by Country, 2018 - 2021, USD Million
• TABLE 272 Asia Pacific Recombinant Proteins Market by Country, 2022 - 2028, USD Million
• TABLE 273 China Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 274 China Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 275 China Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 276 China Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 277 China Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 278 China Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 279 China Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 280 China Recombinant Proteins Market by Application, 2022 - 2028, USD Million
• TABLE 281 Japan Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 282 Japan Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 283 Japan Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 284 Japan Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 285 Japan Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 286 Japan Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 287 Japan Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 288 Japan Recombinant Proteins Market by Application, 2022 - 2028, USD Million
• TABLE 289 India Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 290 India Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 291 India Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 292 India Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 293 India Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 294 India Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 295 India Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 296 India Recombinant Proteins Market by Application, 2022 - 2028, USD Million
• TABLE 297 South Korea Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 298 South Korea Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 299 South Korea Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 300 South Korea Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 301 South Korea Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 302 South Korea Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 303 South Korea Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 304 South Korea Recombinant Proteins Market by Application, 2022 - 2028, USD Million

• TABLE 305 Singapore Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 306 Singapore Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 307 Singapore Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 308 Singapore Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 309 Singapore Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 310 Singapore Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 311 Singapore Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 312 Singapore Recombinant Proteins Market by Application, 2022 - 2028, USD Million
• TABLE 313 Malaysia Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 314 Malaysia Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 315 Malaysia Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 316 Malaysia Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 317 Malaysia Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 318 Malaysia Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 319 Malaysia Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 320 Malaysia Recombinant Proteins Market by Application, 2022 - 2028, USD Million
• TABLE 321 Rest of Asia Pacific Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 322 Rest of Asia Pacific Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 323 Rest of Asia Pacific Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 324 Rest of Asia Pacific Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 325 Rest of Asia Pacific Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 326 Rest of Asia Pacific Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 327 Rest of Asia Pacific Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 328 Rest of Asia Pacific Recombinant Proteins Market by Application, 2022 - 2028, USD Million
• TABLE 329 LAMEA Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 330 LAMEA Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 331 LAMEA Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 332 LAMEA Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 333 LAMEA Growth Factors & Chemokines Market by Country, 2018 - 2021, USD Million
• TABLE 334 LAMEA Growth Factors & Chemokines Market by Country, 2022 - 2028, USD Million
• TABLE 335 LAMEA Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2018 - 2021, USD Million
• TABLE 336 LAMEA Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2022 - 2028, USD Million
• TABLE 337 LAMEA Structural Proteins Market by Country, 2018 - 2021, USD Million
• TABLE 338 LAMEA Structural Proteins Market by Country, 2022 - 2028, USD Million
• TABLE 339 LAMEA Membrane Proteins Market by Country, 2018 - 2021, USD Million
• TABLE 340 LAMEA Membrane Proteins Market by Country, 2022 - 2028, USD Million
• TABLE 341 LAMEA Kinase Proteins & Regulatory Proteins Market by Country, 2018 - 2021, USD Million
• TABLE 342 LAMEA Kinase Proteins & Regulatory Proteins Market by Country, 2022 - 2028, USD Million
• TABLE 343 LAMEA Immune Response Proteins Market by Country, 2018 - 2021, USD Million
• TABLE 344 LAMEA Immune Response Proteins Market by Country, 2022 - 2028, USD Million
• TABLE 345 LAMEA Others Market by Country, 2018 - 2021, USD Million
• TABLE 346 LAMEA Others Market by Country, 2022 - 2028, USD Million
• TABLE 347 LAMEA Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 348 LAMEA Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 349 LAMEA Pharmaceutical & Biopharmaceutical Companies Market by Country, 2018 - 2021, USD Million
• TABLE 350 LAMEA Pharmaceutical & Biopharmaceutical Companies Market by Country, 2022 - 2028, USD Million
• TABLE 351 LAMEA Biotechnology Companies Market by Country, 2018 - 2021, USD Million
• TABLE 352 LAMEA Biotechnology Companies Market by Country, 2022 - 2028, USD Million
• TABLE 353 LAMEA Academic Research Institutes Market by Country, 2018 - 2021, USD Million
• TABLE 354 LAMEA Academic Research Institutes Market by Country, 2022 - 2028, USD Million
• TABLE 355 LAMEA Contract Research Organizations Market by Country, 2018 - 2021, USD Million
• TABLE 356 LAMEA Contract Research Organizations Market by Country, 2022 - 2028, USD Million
• TABLE 357 LAMEA Others Market by Country, 2018 - 2021, USD Million
• TABLE 358 LAMEA Others Market by Country, 2022 - 2028, USD Million
• TABLE 359 LAMEA Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 360 LAMEA Recombinant Proteins Market by Application, 2022 - 2028, USD Million
• TABLE 361 LAMEA Drug Discovery & Development Market by Country, 2018 - 2021, USD Million
• TABLE 362 LAMEA Drug Discovery & Development Market by Country, 2022 - 2028, USD Million
• TABLE 363 LAMEA Academic Research Studies Market by Country, 2018 - 2021, USD Million
• TABLE 364 LAMEA Academic Research Studies Market by Country, 2022 - 2028, USD Million
• TABLE 365 LAMEA Biopharmaceutical Production Market by Country, 2018 - 2021, USD Million
• TABLE 366 LAMEA Biopharmaceutical Production Market by Country, 2022 - 2028, USD Million
• TABLE 367 LAMEA Diagnostics Market by Country, 2018 - 2021, USD Million
• TABLE 368 LAMEA Diagnostics Market by Country, 2022 - 2028, USD Million
• TABLE 369 LAMEA Biotechnology Research Market by Country, 2018 - 2021, USD Million
• TABLE 370 LAMEA Biotechnology Research Market by Country, 2022 - 2028, USD Million
• TABLE 371 LAMEA Others Market by Country, 2018 - 2021, USD Million
• TABLE 372 LAMEA Others Market by Country, 2022 - 2028, USD Million
• TABLE 373 LAMEA Recombinant Proteins Market by Country, 2018 - 2021, USD Million
• TABLE 374 LAMEA Recombinant Proteins Market by Country, 2022 - 2028, USD Million
• TABLE 375 Brazil Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 376 Brazil Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 377 Brazil Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 378 Brazil Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 379 Brazil Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 380 Brazil Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 381 Brazil Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 382 Brazil Recombinant Proteins Market by Application, 2022 - 2028, USD Million
• TABLE 383 Argentina Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 384 Argentina Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 385 Argentina Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 386 Argentina Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 387 Argentina Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 388 Argentina Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 389 Argentina Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 390 Argentina Recombinant Proteins Market by Application, 2022 - 2028, USD Million
• TABLE 391 UAE Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 392 UAE Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 393 UAE Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 394 UAE Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 395 UAE Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 396 UAE Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 397 UAE Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 398 UAE Recombinant Proteins Market by Application, 2022 - 2028, USD Million
• TABLE 399 Saudi Arabia Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 400 Saudi Arabia Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 401 Saudi Arabia Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 402 Saudi Arabia Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 403 Saudi Arabia Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 404 Saudi Arabia Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 405 Saudi Arabia Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 406 Saudi Arabia Recombinant Proteins Market by Application, 2022 - 2028, USD Million
• TABLE 407 South Africa Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 408 South Africa Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 409 South Africa Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 410 South Africa Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 411 South Africa Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 412 South Africa Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 413 South Africa Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 414 South Africa Recombinant Proteins Market by Application, 2022 - 2028, USD Million
• TABLE 415 Nigeria Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 416 Nigeria Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 417 Nigeria Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 418 Nigeria Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 419 Nigeria Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 420 Nigeria Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 421 Nigeria Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 422 Nigeria Recombinant Proteins Market by Application, 2022 - 2028, USD Million
• TABLE 423 Rest of LAMEA Recombinant Proteins Market, 2018 - 2021, USD Million
• TABLE 424 Rest of LAMEA Recombinant Proteins Market, 2022 - 2028, USD Million
• TABLE 425 Rest of LAMEA Recombinant Proteins Market by Product, 2018 - 2021, USD Million
• TABLE 426 Rest of LAMEA Recombinant Proteins Market by Product, 2022 - 2028, USD Million
• TABLE 427 Rest of LAMEA Recombinant Proteins Market by End User, 2018 - 2021, USD Million
• TABLE 428 Rest of LAMEA Recombinant Proteins Market by End User, 2022 - 2028, USD Million
• TABLE 429 Rest of LAMEA Recombinant Proteins Market by Application, 2018 - 2021, USD Million
• TABLE 430 Rest of LAMEA Recombinant Proteins Market by Application, 2022 - 2028, USD Million
• TABLE 431 Key Information - Bio-Techne Corporation
• TABLE 432 Key Information - Thermo Fisher Scientific, Inc.
• TABLE 433 key Information - Merck GrouP
• TABLE 434 Key Information - Bio-Rad Laboratories, Inc.
• TABLE 435 key information - Abcam plc
• TABLE 436 Key information - Genscript Biotech Corporation
• TABLE 437 Key information - Miltenyi Biotec B.V. & Co. KG
• TABLE 438 Key Information - Proteintech Group, Inc.
• TABLE 439 Key Information - BPS Bioscience, Inc.
• TABLE 440 Key Information - RayBiotech Life, Inc.

List of Figures

• FIG 1 Methodology for the research
• FIG 2 Global Recombinant Proteins Market share by Product, 2021
• FIG 3 Global Recombinant Proteins Market share by Product, 2028
• FIG 4 Global Recombinant Proteins Market by Product, 2018 - 2028, USD Million
• FIG 5 Global Recombinant Proteins Market share by End User, 2021
• FIG 6 Global Recombinant Proteins Market share by End User, 2028
• FIG 7 Global Recombinant Proteins Market by End User, 2018 - 2028, USD Million
• FIG 8 Global Recombinant Proteins Market share by Application, 2021
• FIG 9 Global Recombinant Proteins Market share by Application, 2028
• FIG 10 Global Recombinant Proteins Market by Application, 2018 - 2028, USD Million
• FIG 11 Global Recombinant Proteins Market share by Region, 2021
• FIG 12 Global Recombinant Proteins Market share by Region, 2028
• FIG 13 Global Recombinant Proteins Market by Region, 2018 - 2028, USD Million

The Global Recombinant Proteins Market size is expected to reach $2.6 billion by 2028, rising at a market growth of 10.8% CAGR during the forecast period.

Recombinant proteins have a huge future in the study and development of cancer therapies. Examples of recombinant proteins used in cancer therapy research include growth factors, immunological checkpoints, and cell damage & oxidative stress proteins (preclinical stage). The utilization of recombinant proteins including immunological checkpoint, antibodies, and growth factors, for targeted purposes has risen as a result of a greater knowledge of neoplastic signalling cascades and the proteins involved in them.

Researchers utilise these proteins frequently to study how cancer signalling pathways and functions. Research uses recombinant immune checkpoints that directly target programmed death-1 (PD-1) and programmed death ligand-1 and 2 (PD-L1), including PD-1/PD-L1 Inhibitor 1 and PD-1/PD-L1 Inhibitor 2. Aside from that, proteins like CD40 Ligand/TRAP, CD226, and Human CellExp CTLA4/CD152 are often employed in studies on cancer therapy.

Growth in the business is predicted to be fueled by the increased incidence of chronic disorders such granulomatous disease, haemophilia, and sclerosis. Additionally, improved recombinant protein products, the growing preference for biologics and biosimilars, and other reasons all contribute to the industry's expansion. The race to discover cures and diagnostic tools for the SARS-CoV2 virus was fuelled by the COVID-19 epidemic.

With over 400 million people worldwide suffer from uncommon genetic illnesses, according to Global Genes. This figure demonstrates the urgent need for therapies, an improvement in healthcare environments, and increased public knowledge of health issues. A critical instrument for the creation of medicines is the requirement for cutting-edge research and knowledge of drug targeting mechanisms.

Cohort programmes have helped several regions create biobanks that give researchers access to high-quality samples that will revolutionise treatment efforts. This may lead to a greater emphasis on the identification of biomarkers for various illnesses. As an illustration, the FDA approved Ayvakit in August 2022 to address advanced systemic mastocytosis, a rare blood disorder.

COVID-19 Impact Analysis

The requirement for the COVID-19 vaccine to be developed quickly and on a large scale, as well as its ongoing commercial manufacturing activities, had a favourable effect on the development of biologics-based research initiatives and ultimately helped the industry's expansion. The COVID-19 pandemic had a favourable effect on the expansion of the proteins market. Recombinant protein vaccines may be developed with a combination of subunits of different adjuvants and antigens that will be more effective against SARS-CoV-2 infections and be readily available in the centre, it was suggested in light of the growth in COVID infection.

Market Growth Factors

Growing Emphasis On Customised Medicine Due To An Increase In The Prevalence Of Chronic Diseases

Recombinant proteins are one of the few recognised treatments for such conditions, and as chronic illnesses are on the rise, there is a significant demand for recombinant protein therapies. According to GLOBOCAN, there were estimated 195,499 new cancer cases and 90,222 cancer-related deaths in Mexico in 2020. Several biotechnologies, including vaccines, recombinant proteins, and cell and gene therapies, must be incorporated into the development of personalised medicine since they are essential to the personalization of care.

Increasing Biologics Research And Development

The market for recombinant proteins is anticipated to expand in demand due to the increased research and development on biologics. The R&D industry has traditionally required a lot of capital because of lengthy study periods and regulatory delays. Consumption on R&D accounts for a considerable share of global spending. Governments acknowledge R&D as a crucial factor in a nation's development, global competitiveness, and public good. R&D funding and spending have risen steadily as a result.

Market Restraining Factors

Recombinant proteins are getting cheaper.

Recombinant Proteins are made in labs using cells that have been grown, which contributes to their expensive price. Purification of these medications, which can make up as much as 80% of the manufacturing costs, is one of the major expenses. Price erosion is defined as when many players enter a particular market and sell identical products without any uniqueness, saturating the market with less creative and reasonably priced goods. Price erosion is the constant drop in the price of these products in a given market, which slows down market expansion.

Product Outlook

Based on Product, the market for recombinant proteins is classified into growth factors and chemokines, immune response proteins, structural proteins, membrane proteins, kinase proteins, regulatory proteins, recombinant metabolic enzymes, adhesion molecules and receptors, and other recombinant proteins. Immune response proteins are expected to command a sizable sales share in 2021. A crucial group of proteins in the body are cytokines. These little proteins act as immune system messengers. They serve as the immune system's network of communication and are created in reaction to a threat. Immune system cells can sometimes interact by touching one another directly, but more frequently, they do so via secreting cytokines, which can operate on other cells nearby or far away.

Application Outlook

Based on application, the market Drug Discovery & Development, Biopharmaceutical Production, Biotechnology Research, Academic Research Studies, Diagnostics, and Other Applications. The biotechnology research command a significant revenue share in 2021. Recombinant proteins aid in illuminating an organism's basic and underlying principles. These molecules can be used to identify and pinpoint the location of the protein that a particular gene encodes, as well as to learn more about how other genes are involved in processes such as cell signalling, metabolism, growth, replication, and death, as well as translation, transcription, and protein modification.

End User Outlook

Based on End User, the Recombinant Proteins Market is divided in pharmaceutical and biopharmaceutical industry, biotechnology industry, academic research institutes, contract research organisations, and other end users. Contract Research Organizations are expected to account for a sizable portion of market revenue in 2021. The R&D industry saw increased investments in regards to partnerships and collaborations between academic institutions and businesses. For instance, the Center for Therapeutic Innovation (CTI) at Pfizer serves as a forum for interaction among stakeholders in the healthcare system.

Regional Outlook

Based on geography, the Recombinant Proteins Market is classified into North America, Europe, Asia Pacific, and LAMEA. The leading regional market for recombinant proteins in 2021 was North America. The high prevalence of chronic and genetic diseases, the availability of funding for R&D, government initiatives for R&D in the pharmaceutical industry, the growing use of life science techniques in research and academia, the significant presence of major pharmaceutical and biotechnology organizations, and the application of analytical instruments in drug discovery and development are all factors that contribute to North America holding a significant share of the global market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bio-Techne Corporation, Thermo Fisher Scientific, Inc., Merck Group, Bio-Rad Laboratories, Inc., Abcam plc, Genscript Biotech Corporation, Miltenyi Biotec B.V. & Co. KG, Proteintech Group, Inc., BPS Bioscience, Inc., and RayBiotech Life, Inc.

Strategies Deployed in Recombinant Proteins Market

Nov-2022: Abcam comes into agreement with NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research. Through this agreement, Abcam RabMAb™ recombinant antibodies would be produced as part of the first 64-plex protein panel for NanoString's CosMx™ Spatial Molecular Imager (SMI). Additionally, this agreement would open the full capability of spatial biology and help enhance care for people with cancer.

2022-Jul: Bio-Rad Laboratories launched EconoFit Columns, a low-pressure prepacked chromatography column pack. The EconoFit columns are created for resin screening, enabling customers that are designing protein purification workflows to choose the optimal chemistry for various targets. The products offer run-to-run uniformity to support preparative scale purifications and method advancement for the latest target proteins, as well as to improve existing workflows.

Feb-2022: Abcam came into agreement with Twist Bioscience Corporation, a synthetic biology company. Under this agreement, Abcam would use a proprietary Twist VHH phage library for antibody development, discovery, and commercialization for research and diagnostic application. Moreover, Twist Bioscience grants Abcam the right to perform research and development activities utilizing Twist single domain (VHH) synthetic antibody library.

Jan-2022: Thermo Fisher Scientific Inc. completed the acquisition PeproTech, Inc., a leading developer, and manufacturer of recombinant proteins. Through this acquisition, PeproTech's recombinant proteins suite aligns with Thermo Fisher's cell culture media products and would allow Thermo Fisher to offer customers significant advantages through an integrated offering.

2021-Nov: Abcam partnered with Nautilus Biotechnology, Inc., a development-stage life sciences company. Under this partnership, Both companies would focus on the combined advancement of affinity binding reagents used on the Nautilus proteomic analysis system and would broaden in the upcoming time to the large-scale manufacturing and supply of reagents for production.

Mar-2021: Bio-Techne Corporation released Cultrex™ UltiMatrix, a hydrogel extracellular matrix that is beneficial for cultivating pluripotent stem cells and organoids in terms of performance and consistency. The product develops Matriz hydrogels that support the growth use of pluripotent stem and organoid cells for drug research, commercialize medicine, and regenerative medicine.

Nov-2020: Merck signed an agreement with Donghao Lansheng (Group) Co., Ltd., a large modern service industry. This agreement would drive a new process that helps the custom clearing of research material for analytical use and biomedical innovation, through this Merck would be able to process shipments with the technical dossier and fewer application needs.

Nov-2019: Abcam plc announced a partnership with BrickBio, a Tiger Gene suite company and have specialization in site-specific protein modification. Through this partnership, Abcam would have full rights to the platform for the formation of novel conjugation-ready recombinant products for the research equipment market and to produce the platform over its recombinant antibody and protein offering for diagnostic use.

Apr-2019: Bio-Techne Corporation Collaborated with Elpiscience BioPharma, a clinical-stage biopharmaceutical company. Through this collaboration, both companies aimed to advance anti-cancer therapeutics and boost the development of the latest biologics to meet the medical requirements in Oncology.

Apr-2018: Proteintech Group acquired HumanZyme, a manufacturer of recombinant human proteins. Through this acquisition, the company would strengthen its place as a manufacturer of antibodies, ELISA kits, and proteins.

Scope of the Study

Market Segments covered in the Report:

By Product

• Growth Factors & Chemokines
• Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors
• Structural Proteins
• Membrane Proteins
• Kinase Proteins & Regulatory Proteins
• Immune Response Proteins
• Others

By End User

• Pharmaceutical & Biopharmaceutical Companies
• Biotechnology Companies
• Academic Research Institutes
• Contract Research Organizations
• Others

By Application

• Drug Discovery & Development
• Academic Research Studies
• Biopharmaceutical Production
• Diagnostics
• Biotechnology Research
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Bio-Techne Corporation
• Thermo Fisher Scientific, Inc.
• Merck Group
• Bio-Rad Laboratories, Inc.
• Abcam plc
• Genscript Biotech Corporation
• Miltenyi Biotec B.V. & Co. KG
• Proteintech Group, Inc.
• BPS Bioscience, Inc.
• RayBiotech Life, Inc.

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Recombinant Proteins Market, by Product
  • 1.4.2 Global Recombinant Proteins Market, by End User
  • 1.4.3 Global Recombinant Proteins Market, by Application
  • 1.4.4 Global Recombinant Proteins Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market Overview

• 2.1 Introduction
  • 2.1.1 Overview
    • 2.1.1.1 Market Composition and Scenario
• 2.2 Key Factors Impacting the Market
  • 2.2.1 Market Drivers
  • 2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Recombinant Proteins Market

Chapter 4. Global Recombinant Proteins Market by Product

• 4.1 Global Growth Factors & Chemokines Market by Region
• 4.2 Global Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Region
• 4.3 Global Structural Proteins Market by Region
• 4.4 Global Membrane Proteins Market by Region
• 4.5 Global Kinase Proteins & Regulatory Proteins Market by Region
• 4.6 Global Immune Response Proteins Market by Region
• 4.7 Global Others Market by Region

Chapter 5. Global Recombinant Proteins Market by End User

• 5.1 Global Pharmaceutical & Biopharmaceutical Companies Market by Region
• 5.2 Global Biotechnology Companies Market by Region
• 5.3 Global Academic Research Institutes Market by Region
• 5.4 Global Contract Research Organizations Market by Region
• 5.5 Global Others Market by Region

Chapter 6. Global Recombinant Proteins Market by Application

• 6.1 Global Drug Discovery & Development Market by Region
• 6.2 Global Academic Research Studies Market by Region
• 6.3 Global Biopharmaceutical Production Market by Region
• 6.4 Global Diagnostics Market by Region
• 6.5 Global Biotechnology Research Market by Region
• 6.6 Global Others Market by Region

Chapter 7. Global Recombinant Proteins Market by Region

• 7.1 North America Recombinant Proteins Market
  • 7.1.1 North America Recombinant Proteins Market by Product
    • 7.1.1.1 North America Growth Factors & Chemokines Market by Country
    • 7.1.1.2 North America Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country
    • 7.1.1.3 North America Structural Proteins Market by Country
    • 7.1.1.4 North America Membrane Proteins Market by Country
    • 7.1.1.5 North America Kinase Proteins & Regulatory Proteins Market by Country
    • 7.1.1.6 North America Immune Response Proteins Market by Country
    • 7.1.1.7 North America Others Market by Country
  • 7.1.2 North America Recombinant Proteins Market by End User
    • 7.1.2.1 North America Pharmaceutical & Biopharmaceutical Companies Market by Country
    • 7.1.2.2 North America Biotechnology Companies Market by Country
    • 7.1.2.3 North America Academic Research Institutes Market by Country
    • 7.1.2.4 North America Contract Research Organizations Market by Country
    • 7.1.2.5 North America Others Market by Country
  • 7.1.3 North America Recombinant Proteins Market by Application
    • 7.1.3.1 North America Drug Discovery & Development Market by Country
    • 7.1.3.2 North America Academic Research Studies Market by Country
    • 7.1.3.3 North America Biopharmaceutical Production Market by Country
    • 7.1.3.4 North America Diagnostics Market by Country
    • 7.1.3.5 North America Biotechnology Research Market by Country
    • 7.1.3.6 North America Others Market by Country
  • 7.1.4 North America Recombinant Proteins Market by Country
    • 7.1.4.1 US Recombinant Proteins Market
      • 7.1.4.1.1 US Recombinant Proteins Market by Product
      • 7.1.4.1.2 US Recombinant Proteins Market by End User
      • 7.1.4.1.3 US Recombinant Proteins Market by Application
    • 7.1.4.2 Canada Recombinant Proteins Market
      • 7.1.4.2.1 Canada Recombinant Proteins Market by Product
      • 7.1.4.2.2 Canada Recombinant Proteins Market by End User
      • 7.1.4.2.3 Canada Recombinant Proteins Market by Application
    • 7.1.4.3 Mexico Recombinant Proteins Market
      • 7.1.4.3.1 Mexico Recombinant Proteins Market by Product
      • 7.1.4.3.2 Mexico Recombinant Proteins Market by End User
      • 7.1.4.3.3 Mexico Recombinant Proteins Market by Application
    • 7.1.4.4 Rest of North America Recombinant Proteins Market
      • 7.1.4.4.1 Rest of North America Recombinant Proteins Market by Product
      • 7.1.4.4.2 Rest of North America Recombinant Proteins Market by End User
      • 7.1.4.4.3 Rest of North America Recombinant Proteins Market by Application
• 7.2 Europe Recombinant Proteins Market
  • 7.2.1 Europe Recombinant Proteins Market by Product
    • 7.2.1.1 Europe Growth Factors & Chemokines Market by Country
    • 7.2.1.2 Europe Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country
    • 7.2.1.3 Europe Structural Proteins Market by Country
    • 7.2.1.4 Europe Membrane Proteins Market by Country
    • 7.2.1.5 Europe Kinase Proteins & Regulatory Proteins Market by Country
    • 7.2.1.6 Europe Immune Response Proteins Market by Country
    • 7.2.1.7 Europe Others Market by Country
  • 7.2.2 Europe Recombinant Proteins Market by End User
    • 7.2.2.1 Europe Pharmaceutical & Biopharmaceutical Companies Market by Country
    • 7.2.2.2 Europe Biotechnology Companies Market by Country
    • 7.2.2.3 Europe Academic Research Institutes Market by Country
    • 7.2.2.4 Europe Contract Research Organizations Market by Country
    • 7.2.2.5 Europe Others Market by Country
  • 7.2.3 Europe Recombinant Proteins Market by Application
    • 7.2.3.1 Europe Drug Discovery & Development Market by Country
    • 7.2.3.2 Europe Academic Research Studies Market by Country
    • 7.2.3.3 Europe Biopharmaceutical Production Market by Country
    • 7.2.3.4 Europe Diagnostics Market by Country
    • 7.2.3.5 Europe Biotechnology Research Market by Country
    • 7.2.3.6 Europe Others Market by Country
  • 7.2.4 Europe Recombinant Proteins Market by Country
    • 7.2.4.1 Germany Recombinant Proteins Market
      • 7.2.4.1.1 Germany Recombinant Proteins Market by Product
      • 7.2.4.1.2 Germany Recombinant Proteins Market by End User
      • 7.2.4.1.3 Germany Recombinant Proteins Market by Application
    • 7.2.4.2 UK Recombinant Proteins Market
      • 7.2.4.2.1 UK Recombinant Proteins Market by Product
      • 7.2.4.2.2 UK Recombinant Proteins Market by End User
      • 7.2.4.2.3 UK Recombinant Proteins Market by Application
    • 7.2.4.3 France Recombinant Proteins Market
      • 7.2.4.3.1 France Recombinant Proteins Market by Product
      • 7.2.4.3.2 France Recombinant Proteins Market by End User
      • 7.2.4.3.3 France Recombinant Proteins Market by Application
    • 7.2.4.4 Russia Recombinant Proteins Market
      • 7.2.4.4.1 Russia Recombinant Proteins Market by Product
      • 7.2.4.4.2 Russia Recombinant Proteins Market by End User
      • 7.2.4.4.3 Russia Recombinant Proteins Market by Application
    • 7.2.4.5 Spain Recombinant Proteins Market
      • 7.2.4.5.1 Spain Recombinant Proteins Market by Product
      • 7.2.4.5.2 Spain Recombinant Proteins Market by End User
      • 7.2.4.5.3 Spain Recombinant Proteins Market by Application
    • 7.2.4.6 Italy Recombinant Proteins Market
      • 7.2.4.6.1 Italy Recombinant Proteins Market by Product
      • 7.2.4.6.2 Italy Recombinant Proteins Market by End User
      • 7.2.4.6.3 Italy Recombinant Proteins Market by Application
    • 7.2.4.7 Rest of Europe Recombinant Proteins Market
      • 7.2.4.7.1 Rest of Europe Recombinant Proteins Market by Product
      • 7.2.4.7.2 Rest of Europe Recombinant Proteins Market by End User
      • 7.2.4.7.3 Rest of Europe Recombinant Proteins Market by Application
• 7.3 Asia Pacific Recombinant Proteins Market
  • 7.3.1 Asia Pacific Recombinant Proteins Market by Product
    • 7.3.1.1 Asia Pacific Growth Factors & Chemokines Market by Country
    • 7.3.1.2 Asia Pacific Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country
    • 7.3.1.3 Asia Pacific Structural Proteins Market by Country
    • 7.3.1.4 Asia Pacific Membrane Proteins Market by Country
    • 7.3.1.5 Asia Pacific Kinase Proteins & Regulatory Proteins Market by Country
    • 7.3.1.6 Asia Pacific Immune Response Proteins Market by Country
    • 7.3.1.7 Asia Pacific Others Market by Country
  • 7.3.2 Asia Pacific Recombinant Proteins Market by End User
    • 7.3.2.1 Asia Pacific Pharmaceutical & Biopharmaceutical Companies Market by Country
    • 7.3.2.2 Asia Pacific Biotechnology Companies Market by Country
    • 7.3.2.3 Asia Pacific Academic Research Institutes Market by Country
    • 7.3.2.4 Asia Pacific Contract Research Organizations Market by Country
    • 7.3.2.5 Asia Pacific Others Market by Country
  • 7.3.3 Asia Pacific Recombinant Proteins Market by Application
    • 7.3.3.1 Asia Pacific Drug Discovery & Development Market by Country
    • 7.3.3.2 Asia Pacific Academic Research Studies Market by Country
    • 7.3.3.3 Asia Pacific Biopharmaceutical Production Market by Country
    • 7.3.3.4 Asia Pacific Diagnostics Market by Country
    • 7.3.3.5 Asia Pacific Biotechnology Research Market by Country
    • 7.3.3.6 Asia Pacific Others Market by Country
  • 7.3.4 Asia Pacific Recombinant Proteins Market by Country
    • 7.3.4.1 China Recombinant Proteins Market
      • 7.3.4.1.1 China Recombinant Proteins Market by Product
      • 7.3.4.1.2 China Recombinant Proteins Market by End User
      • 7.3.4.1.3 China Recombinant Proteins Market by Application
    • 7.3.4.2 Japan Recombinant Proteins Market
      • 7.3.4.2.1 Japan Recombinant Proteins Market by Product
      • 7.3.4.2.2 Japan Recombinant Proteins Market by End User
      • 7.3.4.2.3 Japan Recombinant Proteins Market by Application
    • 7.3.4.3 India Recombinant Proteins Market
      • 7.3.4.3.1 India Recombinant Proteins Market by Product
      • 7.3.4.3.2 India Recombinant Proteins Market by End User
      • 7.3.4.3.3 India Recombinant Proteins Market by Application
    • 7.3.4.4 South Korea Recombinant Proteins Market
      • 7.3.4.4.1 South Korea Recombinant Proteins Market by Product
      • 7.3.4.4.2 South Korea Recombinant Proteins Market by End User
      • 7.3.4.4.3 South Korea Recombinant Proteins Market by Application
    • 7.3.4.5 Singapore Recombinant Proteins Market
      • 7.3.4.5.1 Singapore Recombinant Proteins Market by Product
      • 7.3.4.5.2 Singapore Recombinant Proteins Market by End User
      • 7.3.4.5.3 Singapore Recombinant Proteins Market by Application
    • 7.3.4.6 Malaysia Recombinant Proteins Market
      • 7.3.4.6.1 Malaysia Recombinant Proteins Market by Product
      • 7.3.4.6.2 Malaysia Recombinant Proteins Market by End User
      • 7.3.4.6.3 Malaysia Recombinant Proteins Market by Application
    • 7.3.4.7 Rest of Asia Pacific Recombinant Proteins Market
      • 7.3.4.7.1 Rest of Asia Pacific Recombinant Proteins Market by Product
      • 7.3.4.7.2 Rest of Asia Pacific Recombinant Proteins Market by End User
      • 7.3.4.7.3 Rest of Asia Pacific Recombinant Proteins Market by Application
• 7.4 LAMEA Recombinant Proteins Market
  • 7.4.1 LAMEA Recombinant Proteins Market by Product
    • 7.4.1.1 LAMEA Growth Factors & Chemokines Market by Country
    • 7.4.1.2 LAMEA Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country
    • 7.4.1.3 LAMEA Structural Proteins Market by Country
    • 7.4.1.4 LAMEA Membrane Proteins Market by Country
    • 7.4.1.5 LAMEA Kinase Proteins & Regulatory Proteins Market by Country
    • 7.4.1.6 LAMEA Immune Response Proteins Market by Country
    • 7.4.1.7 LAMEA Others Market by Country
  • 7.4.2 LAMEA Recombinant Proteins Market by End User
    • 7.4.2.1 LAMEA Pharmaceutical & Biopharmaceutical Companies Market by Country
    • 7.4.2.2 LAMEA Biotechnology Companies Market by Country
    • 7.4.2.3 LAMEA Academic Research Institutes Market by Country
    • 7.4.2.4 LAMEA Contract Research Organizations Market by Country
    • 7.4.2.5 LAMEA Others Market by Country
  • 7.4.3 LAMEA Recombinant Proteins Market by Application
    • 7.4.3.1 LAMEA Drug Discovery & Development Market by Country
    • 7.4.3.2 LAMEA Academic Research Studies Market by Country
    • 7.4.3.3 LAMEA Biopharmaceutical Production Market by Country
    • 7.4.3.4 LAMEA Diagnostics Market by Country
    • 7.4.3.5 LAMEA Biotechnology Research Market by Country
    • 7.4.3.6 LAMEA Others Market by Country
  • 7.4.4 LAMEA Recombinant Proteins Market by Country
    • 7.4.4.1 Brazil Recombinant Proteins Market
      • 7.4.4.1.1 Brazil Recombinant Proteins Market by Product
      • 7.4.4.1.2 Brazil Recombinant Proteins Market by End User
      • 7.4.4.1.3 Brazil Recombinant Proteins Market by Application
    • 7.4.4.2 Argentina Recombinant Proteins Market
      • 7.4.4.2.1 Argentina Recombinant Proteins Market by Product
      • 7.4.4.2.2 Argentina Recombinant Proteins Market by End User
      • 7.4.4.2.3 Argentina Recombinant Proteins Market by Application
    • 7.4.4.3 UAE Recombinant Proteins Market
      • 7.4.4.3.1 UAE Recombinant Proteins Market by Product
      • 7.4.4.3.2 UAE Recombinant Proteins Market by End User
      • 7.4.4.3.3 UAE Recombinant Proteins Market by Application
    • 7.4.4.4 Saudi Arabia Recombinant Proteins Market
      • 7.4.4.4.1 Saudi Arabia Recombinant Proteins Market by Product
      • 7.4.4.4.2 Saudi Arabia Recombinant Proteins Market by End User
      • 7.4.4.4.3 Saudi Arabia Recombinant Proteins Market by Application
    • 7.4.4.5 South Africa Recombinant Proteins Market
      • 7.4.4.5.1 South Africa Recombinant Proteins Market by Product
      • 7.4.4.5.2 South Africa Recombinant Proteins Market by End User
      • 7.4.4.5.3 South Africa Recombinant Proteins Market by Application
    • 7.4.4.6 Nigeria Recombinant Proteins Market
      • 7.4.4.6.1 Nigeria Recombinant Proteins Market by Product
      • 7.4.4.6.2 Nigeria Recombinant Proteins Market by End User
      • 7.4.4.6.3 Nigeria Recombinant Proteins Market by Application
    • 7.4.4.7 Rest of LAMEA Recombinant Proteins Market
      • 7.4.4.7.1 Rest of LAMEA Recombinant Proteins Market by Product
      • 7.4.4.7.2 Rest of LAMEA Recombinant Proteins Market by End User
      • 7.4.4.7.3 Rest of LAMEA Recombinant Proteins Market by Application

Chapter 8. Company Profiles

• 8.1 Bio-Techne Corporation
  • 8.1.1 Company Overview
  • 8.1.2 Financial Analysis
  • 8.1.3 Segmental and Regional Analysis
  • 8.1.4 Research & Development Expenses
  • 8.1.5 Recent strategies and developments:
    • 8.1.5.1 Partnerships, Collaborations, and Agreements:
    • 8.1.5.2 Product Launches and Product Expansions:
• 8.2 Thermo Fisher Scientific, Inc.
  • 8.2.1 Company Overview
  • 8.2.2 Financial Analysis
  • 8.2.3 Segmental and Regional Analysis
  • 8.2.4 Research & Development Expense
  • 8.2.5 Recent strategies and developments:
    • 8.2.5.1 Acquisition and Mergers:
• 8.3 Merck Group
  • 8.3.1 Company Overview
  • 8.3.2 Financial Analysis
  • 8.3.3 Segmental and Regional Analysis
  • 8.3.4 Research & Development Expense
  • 8.3.5 Recent strategies and developments:
    • 8.3.5.1 Partnerships, Collaborations, and Agreements:
• 8.4 Bio-Rad laboratories, Inc.
  • 8.4.1 Company Overview
  • 8.4.2 Financial Analysis
  • 8.4.3 Segmental and Regional Analysis
  • 8.4.4 Research & Development Expenses
  • 8.4.5 Recent strategies and developments:
    • 8.4.5.1 Product Launches and Product Expansions:
• 8.5 Abcam plc
  • 8.5.1 Company Overview
  • 8.5.2 Financial Analysis
  • 8.5.3 Segmental and Regional Analysis
  • 8.5.4 Research & Development Expenses
  • 8.5.5 Recent strategies and developments:
    • 8.5.5.1 Partnerships, Collaborations, and Agreements:
• 8.6 Genscript Biotech Corporation
  • 8.6.1 Company Overview
  • 8.6.2 Financial Analysis
  • 8.6.3 Regional & Segmental Analysis
  • 8.6.4 Research & Development Expenses
• 8.7 Miltenyi Biotech B.V. & Co. KG
  • 8.7.1 Company Overview
• 8.8 Proteintech Group, Inc.
  • 8.8.1 Company Overview
  • 8.8.2 Recent strategies and developments:
    • 8.8.2.1 Acquisition and Mergers:
• 8.9 BPS Bioscience, Inc.
  • 8.9.1 Company Overview
• 8.10. RayBiotech Life, Inc.
  • 8.10.1 Company Overview